Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1996
08/27/1996US5550108 Adding an 18 kda c5b-9 inhibitory protein to prevent platelet and endothelial cell activation
08/27/1996US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established
08/27/1996US5550023 Amplification of human MDM2 gene in human tumors
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
08/22/1996WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996WO1996025506A1 Method for preparing a recombinant adenovirus genome
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025501A2 Method and composition for regulating apoptosis
08/22/1996WO1996025499A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996WO1996025495A1 Sperm factor
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025179A1 Composition and method for production of transformed cells
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213233A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211162A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2188462A1 Method and composition for regulating apoptosis
08/21/1996EP0727490A1 Human-origin prostacyclin synthase
08/21/1996EP0727223A1 Polyamino acid oligonucleotide carrier
08/21/1996EP0726948A1 Method of inducing and maintaining neuronal cells
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation
08/21/1996EP0671923A4 Liver reserve cells.
08/20/1996US5547932 Transfection
08/20/1996US5547467 Method for measuring a blood component content of blood
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024672A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
08/15/1996WO1996024669A1 Human pancreatic cell lines: developments and uses
08/15/1996WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1
08/15/1996WO1996024604A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996WO1996024603A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
08/15/1996WO1996024380A1 Methods and compositions for regulation of cd28 expression
08/15/1996WO1996024379A1 Cancer control
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024360A1 Compound delivery using high-pressure impulse transients
08/15/1996WO1996024357A1 Novel glucocorticoid response elements
08/15/1996WO1996015240A3 Ribozyme analogs
08/15/1996WO1996015144A3 Chromosome 21 gene marker, compositions and methods using same
08/15/1996WO1996013598A3 Hybrid adenovirus-aav virus and method of use thereof
08/15/1996WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
08/15/1996CA2212731A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212573A1 Nucleotide and deduced amino acid sequences of tumor gene int6
08/15/1996CA2212379A1 Novel glucocorticoid response elements
08/15/1996CA2212376A1 Ink4c-p18 and ink4d-p19, inhibitors of cyclin-dependent kinases cdk4 andcdk6, and uses thereof
08/15/1996CA2211621A1 Methods and compositions for regulation of cd28 expression
08/15/1996CA2210685A1 Human pancreatic cell lines: developments and uses
08/15/1996CA2210471A1 Human chemokine beta-11 and human chemokine alpha-1
08/14/1996EP0725830A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
08/14/1996EP0725828A1 Methods relating to ir-95
08/14/1996EP0725826A1 Improvements relating to cancer therapy
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725791A1 Recombinant p53 adenovirus methods and compositions
08/14/1996EP0725788A1 2'-amido and 2'-peptido modified oligonucleotides
08/14/1996CN1128935A Wild-type multiple tumour suppressor (MTS) gene and mutant sequences-useful in diagnosis, prognosis and therapy of human cancer e.g. melanoma or leukaemia
08/14/1996CN1128798A Series of cDNA for improving tumour cells differentiation and carrier for eucaryon expression thereof, and application
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
08/13/1996US5545130 For implanting molecules into living blood cells of a patient
08/08/1996WO1996023889A1 Recombinant rna viral vector and method of preparing the same
08/08/1996WO1996023888A1 NOVEL c-MPL LIGANDS
08/08/1996WO1996023884A2 Human peroxisome proliferator activated receptors
08/08/1996WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996DE19503082A1 Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen Subject and methods of preferred transient expression and possible translation of specific RNA in the cytoplasmic region of higher eukaryotic cells
08/08/1996CA2212006A1 Novel c-mpl ligands
08/08/1996CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
08/07/1996EP0725141A1 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland
08/07/1996EP0724642A1 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724589A1 A method for enhancing neurone survival and agents useful for same
08/07/1996EP0724588A1 Drug binding protein
08/06/1996US5543399 Cystic fibrosis transmembrane conductance regulator (CFTR) protein
08/06/1996US5543328 Adenoviruses having modified fiber proteins
08/01/1996WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
08/01/1996WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness
08/01/1996WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996WO1996022792A1 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
08/01/1996WO1996022765A1 Stable lipid-comprising drug delivery complexes and methods for their production
08/01/1996WO1996022688A1 A proliferation-inhibiting gene sequence and its use in the treatment of cancer and other diseases
08/01/1996WO1996012811A3 Yeast telomerase components and methods using them
08/01/1996WO1996012006A3 Flow through electroporation apparatus and method
08/01/1996WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
08/01/1996CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
07/1996
07/31/1996EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin
07/31/1996EP0723587A1 Deoxyribonucleic acids containing inactivated hormone responsive elements
07/31/1996EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof
1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 870